Skip to main content

Find Clinical Trials

Home
Conditions
Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients

Clinical trial condition

Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients

Explore clinical trials studying Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients trial results

Not Yet Recruiting

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

NCT07035821

Conditions: Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients, Neoplasms, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Shanghai Children's Medical Center Shanghai, China

View Trial Details